Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Rubomycin

Client Email

Product

Rubomycin
U.S. EXCLUSIVITIES

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Rubomycin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 1 USDMF, 1 NDC API, 5 Listed Suppliers, $ API Reference Price

6 API Suppliers
1 USDMF
1 NDC API
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 1 FDA Orange Book, 4 Europe, 1 Canada, 1 South Africa, 3 Listed Dossiers

10 FDF Dossiers
1 FDA Orange Book
4 Europe
1 Canada
1 South Africa
3 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Pfanstiehl, 1 Actylis, 1 Gangwal Chemicals, 3 Nippon Fine Chemical

1 DKSH
1 Pfanstiehl
1 Actylis
1 Gangwal Chemicals
3 Nippon Fine Chemical

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Taste Masking, 2 Thickeners and Stabilizers, 2 Coating Systems & Additives, 2 Topical, 1 Solubilizers, 1 Surfactant & Foaming Agents, 1 Co-Processed Excipients, 1 Emulsifying Agents

3 Parenteral
2 Taste Masking
2 Thickeners and Stabilizers
2 Coating Systems & Additives
2 Topical
1 Solubilizers
1 Surfactant & Foaming Agents
1 Co-Processed Excipients
1 Emulsifying Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 25 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices, 5 Annual Reports

4 Finished Drug Prices
5 Annual Reports

MARKET PLACE

1 APIs, 6 FDF Dossiers

1 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 3 US Exclusivities

10 US Patents
3 US Exclusivities

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 37,591 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 3CELATOR PHARMS

filter Product Reset all filters

3 All

01 3CYTARABINE; DAUNORUBICIN

filter Exclusivity Expiration Date Reset all filters

3 All

01 12024-03-30

02 12024-08-03

03 12028-03-30

filter Exclusivity Code Reset all filters

3 All

01 1NPP

02 1ODE-287

03 1ODE-350

US Patents
US Exclusivities

Product Main Page

CELATOR PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CYTARABINE; DAUNORUBICIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-287

Exclusivity Expiration Date

2024-08-03

Application Number

209401

Product Number

1

Exclusivity Details

01

CELATOR PHARMS

CYTARABINE; DAUNORUBICIN

AAPS 2024

Not Confirmed

CELATOR PHARMS

Ireland

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CYTARABINE; DAUNORUBICIN

Exclusivity Code : ODE-287

Exclusivity Expiration Date : 2024-08-03

Application Number : 209401

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CELATOR PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CYTARABINE; DAUNORUBICIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2024-03-30

Application Number

209401

Product Number

1

Exclusivity Details

02

CELATOR PHARMS

CYTARABINE; DAUNORUBICIN

AAPS 2024

Not Confirmed

CELATOR PHARMS

Ireland

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CYTARABINE; DAUNORUBICIN

Exclusivity Code : NPP

Exclusivity Expiration Date : 2024-03-30

Application Number : 209401

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CELATOR PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CYTARABINE; DAUNORUBICIN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-350

Exclusivity Expiration Date

2028-03-30

Application Number

209401

Product Number

1

Exclusivity Details

03

CELATOR PHARMS

CYTARABINE; DAUNORUBICIN

AAPS 2024

Not Confirmed

CELATOR PHARMS

Ireland

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CYTARABINE; DAUNORUBICIN

Exclusivity Code : ODE-350

Exclusivity Expiration Date : 2028-03-30

Application Number : 209401

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?